These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2223395)

  • 1. Adoptive cellular therapy.
    Urba WJ; Longo DL
    Cancer Chemother Biol Response Modif; 1990; 11():265-80. PubMed ID: 2223395
    [No Abstract]   [Full Text] [Related]  

  • 2. Adoptive immunotherapy with recombinant interleukin 2, LAK and TIL.
    Kurnick JT; Kradin RL
    Allergol Immunopathol (Madr); 1991; 19(5):209-14. PubMed ID: 1811418
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical use of interleukin-2 in treating cancer.
    Patterson DL; Wiemann MC
    Indiana Med; 1991 Aug; 84(8):534-7. PubMed ID: 1918915
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quality control of biological therapy in patients with tumors].
    Zhang S
    Zhonghua Yi Xue Za Zhi; 1996 Jul; 76(7):483-4. PubMed ID: 9275493
    [No Abstract]   [Full Text] [Related]  

  • 5. [Our experience with lymphocytes activated against cancer: CTL cells].
    Marcellino LR; Vinciguerra M; Marcellino MV; Sessa E
    G Chir; 1997 Oct; 18(10):605-7. PubMed ID: 9479972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular immunotherapy of cancer].
    Kawakami Y
    Rinsho Ketsueki; 2003 Jun; 44(6):358-67. PubMed ID: 12884813
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy with interleukin-2 and tumor-derived activated lymphocytes.
    Oldham RK
    Immunol Ser; 1994; 61():251-71. PubMed ID: 8011748
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphokine-activated killer lymphocytes: biotherapeutics clinical trials.
    West WH
    Immunol Ser; 1989; 48():79-92. PubMed ID: 2488327
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphokine-activated killer lymphocytes: extramural clinical trials.
    Sniecinski IJ
    Immunol Ser; 1989; 48():59-77. PubMed ID: 2488326
    [No Abstract]   [Full Text] [Related]  

  • 10. Adoptive cellular immunotherapy for cancer: interleukin-2 activated lymphocytes.
    Wolf JA; Grimm EA
    Curr Opin Oncol; 1989 Dec; 1(2):249-57. PubMed ID: 2489968
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adoptive immunotherapy in patients with multiple hepatic cancers using lymphokine activated killer cells (LAK) and interleukin-2].
    Kanai T; Monden M; Takeda T; Gotoh M; Sakon M; Umeshita K; Hasuike Y; Sakita I; Nakano H; Yoshida T
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1457-60. PubMed ID: 8396896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive cellular therapy.
    Sznol M; Urba WJ
    Cancer Chemother Biol Response Modif; 1991; 12():213-30. PubMed ID: 1931444
    [No Abstract]   [Full Text] [Related]  

  • 13. Adoptive immunotherapy with adherent lymphokine-activated killer (A-LAK) cells in glioblastoma multiforme.
    Munari L; Silvani A; Passerini CG; Radrizzani M; Parmiani G; Boiardi A
    J Neurosurg Sci; 1990; 34(3-4):283-8. PubMed ID: 1965907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokine-activated killer lymphocytes: National Cancer Institute clinical trials.
    Clark J; Longo DL
    Immunol Ser; 1989; 48():37-58. PubMed ID: 2488325
    [No Abstract]   [Full Text] [Related]  

  • 15. [A history and prospect of adoptive immunotherapy against malignant glioma--past, now and future].
    Nitta T
    No To Shinkei; 1992 Jul; 44(7):605-13. PubMed ID: 1419336
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.
    Pierce WC; Belldegrun A; Figlin RA
    Semin Oncol; 1995 Feb; 22(1):74-80. PubMed ID: 7855622
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment with pentoxifylline and ciprofloxacin reduces the toxicity of high-dose interleukin-2 and lymphokine-activated killer cells.
    Thompson JA; Benyunes MC; Bianco JA; Fefer A
    Semin Oncol; 1993 Dec; 20(6 Suppl 9):46-51. PubMed ID: 8284692
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunotherapy of malignant melanoma].
    Flageul B; Miclea JM; Bensussan A; Degos L
    Pathol Biol (Paris); 1990 Oct; 38(8):881-2. PubMed ID: 2274397
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of metastatic melanoma with interleukin-2].
    Chosidow O; Guillaume JC
    Ann Dermatol Venereol; 1992; 119(1):65-73. PubMed ID: 1373275
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical/technical challenges in adoptive cellular immunotherapy: in vitro culture techniques.
    Yannelli JR; Jadus MR; Beckner S; Lacerna LV; Oldham RK
    Immunol Ser; 1989; 48():191-206. PubMed ID: 2488322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.